Table 3 Patient characteristics by study phase

Age

Age = 43.93, range 14–94

Age = 46.66, 12–95

Gender

M 41 (36%)

M 137 (46%)

F 66 (58%)

F 163 (54%))

Missing info 6 (5%)

TB

4/113 (3.5%)

14/300 (4.6%)

HIV

8/113 (7.1%)

23/300 (7.7%)

Malignancies

35/113 (31%)

172/300 (57.3%)

Heart disease

10/113 (8.8%)

19/300 (8.3%)

Kidney disease

4/113 (3.5%)

3/300 (1%)

Lung disease

3/113 (2.7%)

13/300 (4.3%)